The impact of the pandemic reversed a years-long trend of decline in ROI for life science R&D. This momentum is accelerating the adoption of technology and laying the groundwork for further optimization.
Join industry thought leaders from Janssen Pharmaceuticals, Tyra Bio, and Elevar Therapeutics, as they discuss the emerging technologies that are designed to prioritize the human side of life science – the voices of patients, investigators, and other key stakeholders.
In this webinar, you will discover:
- The current state of gathering patient insights – what are the challenges?
- The need for quick and comprehensive uptake of emerging technologies
- The future of insights gathering for clinical teams – what does human-centric look like?
